Carta enviada por Ricardo del Arco a Justo Garate en 1930

1 carta (mecanografiada) ; 213x165mm. Ubicación: Caja 1 - Carpeta 43

Le système monétaire international comme facteur d'instabilité: une ébauche de réforme

371 p.

Nuevos materiales arqueológicos de la cueva de «El Arco B» (Ramales de la Victoria, Cantabria)

[ES] Se presentan un colgante lítico decorado y una placa caliza con pintura localizados en la cueva de El Arco B. Ambas piezas fueron recuperadas en superficie, sin un contexto estratigráfico preciso. La evaluación de la materia prima, de la morfología del soporte y de la decoración del colgante apuntan a considerar, como probable, su pertenencia al Paleolítico superior inicial. La placa decorada no encuentra paralelos claros en el frente cantábrico, por lo cual no es posible precisar más allá de una genérica adscripción al Paleolítico superior. Los materiales arqueológicos y las pinturas rojas ya conocidos, y las nuevas evidencias aquí presentadas, apuntan a considerar el yacimiento de El Arco B como un importante centro de hábitat y de creación artística.

A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12

Background: Colorectal cancer (CRC) is a disease of complex aetiology, with much of the expected inherited risk being due to several common low risk variants. Genome-Wide Association Studies (GWAS) have identified 20 CRC risk variants. Nevertheless, these have only been able to explain part of the missing heritability. Moreover, these signals have only been inspected in populations of Northern European origin. Results: Thus, we followed the same approach in a Spanish cohort of 881 cases and 667 controls. Sixty-four variants at 24 loci were found to be associated with CRC at p-values <10-5. We therefore evaluated the 24 loci in another Spanish replication cohort (1481 cases and 1850 controls). Two of these SNPs, rs12080929 at 1p33 (P-replication=0.042; P-pooled=5.523x10(-03); OR (CI95%)=0.866(0.782-0.959)) and rs11987193 at 8p12 (P-replication=0.039; P-pooled=6.985x10(-5); OR (CI95%)=0.786(0.705-0.878)) were replicated in the second Phase, although they did not reach genome-wide statistical significance. Conclusions: We have performed the first CRC GWAS in a Southern European population and by these means we were able to identify two new susceptibility variants at 1p33 and 8p12 loci. These two SNPs are located near the SLC5A9 and DUSP4 loci, respectively, which could be good functional candidates for the association signals. We therefore believe that these two markers constitute good candidates for CRC susceptibility loci and should be further evaluated in other larger datasets. Moreover, we highlight that were these two SNPs true susceptibility variants, they would constitute a decrease in the CRC missing heritability fraction.

Evidence for classification of c.1852_1853AA > GC in MLH1 as a neutral variant for Lynch syndrome

Background: Lynch syndrome (LS) is an autosomal dominant inherited cancer syndrome characterized by early onset cancers of the colorectum, endometrium and other tumours. A significant proportion of DNA variants in LS patients are unclassified. Reports on the pathogenicity of the c.1852_1853AA>GC (p.Lys618Ala) variant of the MLH1 gene are conflicting. In this study, we provide new evidence indicating that this variant has no significant implications for LS. Methods: The following approach was used to assess the clinical significance of the p.Lys618Ala variant: frequency in a control population, case-control comparison, co-occurrence of the p.Lys618Ala variant with a pathogenic mutation, co-segregation with the disease and microsatellite instability in tumours from carriers of the variant. We genotyped p.Lys618Ala in 1034 individuals (373 sporadic colorectal cancer [CRC] patients, 250 index subjects from families suspected of having LS [revised Bethesda guidelines] and 411 controls). Three well-characterized LS families that fulfilled the Amsterdam II Criteria and consisted of members with the p.Lys618Ala variant were included to assess co-occurrence and co-segregation. A subset of colorectal tumour DNA samples from 17 patients carrying the p.Lys618Ala variant was screened for microsatellite instability using five mononucleotide markers. Results: Twenty-seven individuals were heterozygous for the p.Lys618Ala variant; nine had sporadic CRC (2.41%), seven were suspected of having hereditary CRC (2.8%) and 11 were controls (2.68%). There were no significant associations in the case-control and case-case studies. The p.Lys618Ala variant was co-existent with pathogenic mutations in two unrelated LS families. In one family, the allele distribution of the pathogenic and unclassified variant was in trans, in the other family the pathogenic variant was detected in the MSH6 gene and only the deleterious variant co-segregated with the disease in both families. Only two positive cases of microsatellite instability (2/17, 11.8%) were detected in tumours from p.Lys618Ala carriers, indicating that this variant does not play a role in functional inactivation of MLH1 in CRC patients. Conclusions: The p.Lys618Ala variant should be considered a neutral variant for LS. These findings have implications for the clinical management of CRC probands and their relatives.

Association between CASP8-652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Study

The common 2652 6N del variant in the CASP8 promoter (rs3834129) has been described as a putative low-penetrance risk factor for different cancer types. In particular, some studies suggested that the deleted allele (del) was inversely associated with CRC risk while other analyses failed to confirm this. Hence, to better understand the role of this variant in the risk of developing CRC, we performed a multi-centric case-control study. In the study, the variant 2652 6N del was genotyped in a total of 6,733 CRC cases and 7,576 controls recruited by six different centers located in Spain, Italy, USA, England, Czech Republic and the Netherlands collaborating to the international consortium COGENT (COlorectal cancer GENeTics). Our analysis indicated that rs3834129 was not associated with CRC risk in the full data set. However, the del allele was under-represented in one set of cases with a family history of CRC (per allele model OR = 0.79, 95% CI = 0.69-0.90) suggesting this allele might be a protective factor versus familial CRC. Since this multi-centric case-control study was performed on a very large sample size, it provided robust clarification of the effect of rs3834129 on the risk of developing CRC in Caucasians.

Phosphorylation of the carboxy-terminal domain of histone H1: effects on secondary structure and DNA condensation

Linker histone H1 plays an important role in chromatin folding. Phosphorylation by cyclin-dependent kinases is the main post-translational modification of histone H1. We studied the effects of phosphorylation on the secondary structure of the DNA-bound H1 carboxy-terminal domain (CTD), which contains most of the phosphorylation sites of the molecule. The effects of phosphorylation on the secondary structure of the DNA-bound CTD were site-specific and depended on the number of phosphate groups. Full phosphorylation significantly increased the proportion of -structure and decreased that of -helix. Partial phosphorylation increased the amount of undefined structure and decreased that of -helix without a significant increase in -structure. Phosphorylation had a moderate effect on the affinity of the CTD for the DNA, which was proportional to the number of phosphate groups. Partial phosphorylation drastically reduced the aggregation of DNA fragments by the CTD, but full phosphorylation restored to a large extent the aggregation capacity of the unphosphorylated domain. These results support the involvement of H1 hyperphosphorylation in metaphase chromatin condensation and of H1 partial phosphorylation in interphase chromatin relaxation. More generally, our results suggest that the effects of phosphorylation are mediated by specific structural changes and are not simply a consequence of the net charge.

Avances en espectrometría de masas con fuente de plasma: Análisis simultáneo de elementos mayores y trazas mediante Q-ICP-MS y análisis isotópicos de Sm-Nd mediante HR-MC-ICP-MS. Aplicación en estudios geoquímicos

186 p. : il.

Presio ultzeren agerpen arriskua: Iritzi klinikoa eta balorazio eskalen arteko konparaketa

Presio ultzerak osasun publikoaren arazo bat dira, asaldura fisiko, psikologiko, ekonomiko eta sozial asko eragiten dituztelako. Ultzerak tratatzeko hainbat modu ezagutzen dira, baina argi dago tratamendu onena prebentzioa dela. Haien agerpena saihesteko ezinbestekoa da ultzera bat pairatzeko arriskua baloratzea. Hau egiteko profesionalek iritzi edo epaiketa klinikoa erabili dezakete (haien esperientziaren bitartez ultzera begi bistaz baloratu) edo eskala protokolizatuak erabili ditzakete. Lan honetan, berrikuspen bibliografiko baten bitartez, gehien erabiltzen diren balorazio eskalei buruzko informazioa lortu da. Beste aldetik, iritzi klinikoaren eta balorazio eskalen eraginkortasun klinikoa konparatu da. Azkenik, eskalak euren artean konparatu dira, bakoitzaren ezaugarriak aztertuz. Eskala asko argitaratu egin dira denboran zehar baina gehien balioztatuak eta erabilienak bost dira: Braden, Norton, EMINA, Waterlow eta Cubbin-Jackson. Eskalen artean Braden eta Norton dira eraginkorrenak (hurrenez hurren), Waterlow postu baxuago batean geratuz. EMINA gutxiago erabiltzen da, baina bere eraginkortasuna Braden-en antzekoa da. Dena den, hau baieztatzeko ikerketa gehiago behar dira. Cubbin-Jackson oso eraginkorra da ere baina bere erabilpena paziente akutuetan bereizita dago. Eskalen harrera profesionalen partetik nahiko ona izan da. Haien erabilpena erraza dela diote gehienek, eta ia erdiek metodo hau erabiltzen dute arriskua baloratzeko. %20ak epaiketa eta eskalak batera erabiltzen dituzte, eskalei garrantzia handiena emanez. Frogatu izan da eskalek epaiketa klinikoarekin konparatuz sentsibilitate altuagoa daukatela, hau da, arriskuan dauden paziente kopuru gehiago detektatuko dituztela, nahiz eta bi metodoen efikazia antzekoa izan. Eskalek beraz, faktore gehiago kontuan hartu eta pazientea modu zehatzago batean aztertzen dute. Orokorrean esan daiteke eskalak eraginkorrak direla baina ikerketa gehiago behar dira balidazio sakonago bat egiteko.

Babelium Project: Android gailuetarako Adobe AIR prototipoa

Android gailu eramangarrietan erabiltzeko Babelium Project-en prototipoa.

Evolución geodinámica poliorogénica de los dominios septentrionales de la zona de Ossa Morena

377 p.

Modelization and analysis of the electric arc in low voltage circuit breakers

246 p.

Evaluación del impacto radiológico ambiental de una industria NORM

[ES]El proceso de soldadura más común es la soldadura por arco metálico con electrodos revestidos. A veces ese revestimiento contiene materiales radiactivos de origen natural (NORMs). En España los electrodos más utilizados son los recubiertos de rutilo mezclado con otros materiales. El rutilo contiene algunos radionúclidos naturales detectables, por lo que puede ser considerado como un NORM. Este trabajo principalmente se centra en la aplicación de la metodología expuesta en la Guía de Seguridad 11.3 del Consejo de Seguridad Nuclear (Metodología para la evaluación del impacto radiológico en las industrias NORM), como una herramienta para obtener las dosis en una fábrica que produce este tipo de electrodo y evaluar el impacto radiológico en una instalación específica. Para ello, se aplicaron en dicha instalación los pasos requeridos por la metodología para su cumplimiento. Se analizaron los beneficios inherentes al estudio y se identificaron las zonas de radiación más altas así como la posición de los trabajadores. Habiendo hecho uso de evaluaciones de dosis llevadas a cabo con anterioridad por otros procedimientos, métodos de simulación, se establecieron las pautas de protección radiológica a seguir para el cumplimiento de dicha guía, mediante la colocación de dosímetros personales y monitores de radiación.

The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer: Genetic Association Study in 18,723 Individuals

Colorectal cancer is one of the most frequent neoplasms and an important cause of mortality in the developed world. Mendelian syndromes account for about 5% of the total burden of CRC, being Lynch syndrome and familial adenomatous polyposis the most common forms. Lynch syndrome tumors develop mainly as a consequence of defective DNA mismatch repair associated with germline mutations in MLH1, MSH2, MSH6 and PMS2. A significant proportion of variants identified by screening these genes correspond to missense or noncoding changes without a clear pathogenic consequence, and they are designated as "variants of uncertain significance'', being the c.1852_1853delinsGC (p.K618A) variant in the MLH1 gene a clear example. The implication of this variant as a low-penetrance risk variant for CRC was assessed in the present study by performing a case-control study within a large cohort from the COGENT consortium-COST Action BM1206 including 18,723 individuals (8,055 colorectal cancer cases and 10,668 controls) and a case-only genotype-phenotype correlation with several clinical and pathological characteristics restricted to the Epicolon cohort. Our results showed no involvement of this variant as a low-penetrance variant for colorectal cancer genetic susceptibility and no association with any clinical and pathological characteristics including family history for this neoplasm or Lynch syndrome.

Association between CASP8-652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Study

The common 2652 6N del variant in the CASP8 promoter (rs3834129) has been described as a putative low-penetrance risk factor for different cancer types. In particular, some studies suggested that the deleted allele (del) was inversely associated with CRC risk while other analyses failed to confirm this. Hence, to better understand the role of this variant in the risk of developing CRC, we performed a multi-centric case-control study. In the study, the variant 2652 6N del was genotyped in a total of 6,733 CRC cases and 7,576 controls recruited by six different centers located in Spain, Italy, USA, England, Czech Republic and the Netherlands collaborating to the international consortium COGENT (COlorectal cancer GENeTics). Our analysis indicated that rs3834129 was not associated with CRC risk in the full data set. However, the del allele was under-represented in one set of cases with a family history of CRC (per allele model OR = 0.79, 95% CI = 0.69-0.90) suggesting this allele might be a protective factor versus familial CRC. Since this multi-centric case-control study was performed on a very large sample size, it provided robust clarification of the effect of rs3834129 on the risk of developing CRC in Caucasians.